Skip to content

AnaptysBio, Inc. ANAB Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$84.63M+48.9%-$132.59M+22.1%-$140.62M+13.9%
$543K-7.8%$559K-7.8%$573K-8.5%$577K-9.8%$589K-9.2%
$41.12M+24.3%$36.07M+5.9%$35.75M+5.2%$34.78M+3.5%$33.09M-4.0%
$4.48M+104%$19.7M+115%-$144.97M-40.7%-$127.71M+1.3%-$108.78M+18.5%
$69K-81.1%$87K-75.7%$349K-6.9%$372K-25.9%$366K-44.5%
$248.17M$228.03M
$64.2M+1,216%$68.63M+14,950%$65.7M$55.98M$4.88M
-$102.81M-192%-$132.61M-204%-$61.91M-166%$19.71M-1.6%$112.1M+417%
$149.83M$115.12M
$4.41M+104%$19.61M+114%-$145.32M-40.6%-$128.08M+1.4%-$109.15M+18.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does AnaptysBio, Inc. generate?
AnaptysBio, Inc. (ANAB) generated $4.5M in operating cash flow over the trailing twelve months.
What is AnaptysBio, Inc.'s free cash flow?
After $69.0K of capital expenditures, AnaptysBio, Inc.'s free cash flow was $4.4M over the trailing twelve months, up 104.0% year over year.
Where does AnaptysBio, Inc.'s cash flow data come from?
Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.